Bolt Biotherapeutics, Inc.
Price Action
Technical Summary
WEAKENINGBolt Biotherapeutics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 18), showing significant lag compared to the market leaders. Earnings contraction of 12% provides fundamental context to the price action. Investors should exercise caution due to high volatility (71% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.69 | -9.02% | BELOW |
| 50 SMA | $4.76 | -10.38% | BELOW |
| 100 SMA | $4.76 | -10.34% | BELOW |
| 150 SMA | $5.03 | -15.20% | BELOW |
| 200 SMA | $5.14 | -16.94% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BOLT in an uptrend right now?
BOLT has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is BOLT overbought or oversold?
BOLT's RSI (14) is 34. The stock is in neutral territory, neither overbought nor oversold.
Is BOLT outperforming the market?
BOLT has a Relative Strength (RS) Rating of 18 out of 99. BOLT is currently lagging the broader market.
Where is BOLT in its 52-week range?
BOLT is trading at $4.26, which is 59% of its 52-week high ($7.20) and 15% above its 52-week low ($3.75).
How volatile is BOLT?
BOLT has a Beta of 1.06 and 52-week volatility of 71%. It's more volatile than the S&P 500 - expect bigger swings.